Biofrontera Inc. provided earnings guidance for the fiscal year of 2022. For the period, the company expects total revenues to increase by at least 30% compared with 2021, including typical seasonal strength in the first and fourth quarters.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | +2.80% | -5.98% | -60.29% |
May. 16 | Transcript : Biofrontera Inc., Q1 2024 Earnings Call, May 16, 2024 | |
May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.29% | 5.6M | |
+34.35% | 705B | |
+31.10% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.06% | 238B | |
-3.64% | 210B | |
+10.12% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- BFRI Stock
- News Biofrontera Inc.
- Biofrontera Inc. Provides Earnings Guidance for the Fiscal Year of 2022